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XiuChun Yu*, Ming Xu, SongFeng Xu and ZhiHou FuAbstract
Background: Giant cell tumor of the sacrum, especially involving the sacroiliac joint, is rare, but is particularly
challenging to treat. The long term outcome of a patient was studied with giant cell tumor involving the sacroiliac
joint treated with selective arterial embolization and curretage.
Method: One patient with giant cell tumor involving the sacroiliac joint was treated with selective arterial
embolization and curettage in our hospital in October 2002. The curettage and bone grafting was done after two
times of selective arterial embolization;1600 ml of blood were transfused and no complications developed during
the operation.
Results: At the final follow-up of 9 years after the operation, no local recurrence and metastasis developed and she
retained normal activity in daily life.
Conclusion: We think it is an optimal treatment for giant cell tumor involving the sacroiliac joint, with repeated
selective arterial embolization and curettage, which has the advantage of less injury, less blood loss and fewer
complications.
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Giant cell tumor (GCT) is a locally aggressive, benign
bone tumor with a high risk of local recurrence and a
low risk of metastasis after treatment. Giant cell tumor
of the sacrum, especially involving the sacroiliac joint, is
rare, but is particularly challenging to treat since the
tumor is frequently diagnosed late, and is often quite ex-
tensive within the bone and surrounds the sacral nerve
roots. The sacral canal can accommodate large, slowly
growing GCTs that become symptomatic only when they
become large enough to compress adjacent nerves or
pelvic organs. Patients often present with nonspecific
low back pain. Treatment of GCT involving the sacro-
iliac joint is not straightforward. Excision of the affected
sacral and iliac bone almost always results in loss of* Correspondence: yxch36@yahoo.com.cn
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reproduction in any medium, provided the orfunction of the sacral nerve roots with incontinence and
lumbopelvic discontinuity. Resection of a considerable
portion of the sacrum has a high incidence of neuro-
logical complications, which may affect bowel and blad-
der control and may lead to impotence in men [1].
Curettage alone is challenging due to blood loss and
potential damage to nerve roots, and complete removal
of the tumor is unlikely, with a high risk of recurrence
[2]. Repeated selective arterial embolization (RSAE) of
the tumor has had some success, but is usually used as a
precursor to surgery to decrease bleeding [1,3,4].
In this manuscript, we report the long-term clinical
outcome of a case with GCT involving the sacroiliac
joint that was successfully managed by twice performing
RSAE and curettage, and bone grafting. We stress the
effectiveness of the procedure as being a less invasive
and less complicated primary treatment for GCT of the
sacrum and ilium. Informed consent was given beforeThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 2 Macroscopic features of the pathological specimen
obtained by percutaneous puncture biopsy. Typical appearance of
giant cell tumor of bone with large osteoclast-like giant cells and
uniform ovoid mononuclear cells (HE Hematoxylin & Eosin (HE) × 40).
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concerning the case would be submitted for publication.
Case presentation
A 31-year-old woman presented with severe pain in her
left lower back and buttock, which severely restricted
her gait. Radiography and computerized tomography
(CT) revealed an eccentric geographic destructive osteolytic
lesion involving the sacrum and the posterior superior
iliac spine (Figure 1). A huge soft tissue mass had
extended extra-osseously. After these imaging studies,
the patient underwent a percutaneous puncture biopsy.
The histological diagnosis was GCT of the bone
(Figure 2). Intralesional embolization was performed
using femoral access to selectively embolize the main
arteries feeding the tumor. A catheter was advanced from
the femoral artery into the internal iliac artery, and a
selective angiogram was obtained to identify arteries of
sufficient caliber to facilitate embolization. Injection of
contrast medium showed a hypervascular, destructive
tumor of the sacrum and ilium. Arteriography at the time
of presentation showed markedly increased vascularity
(Figure 3). These feeding branches were selectively
embolized with 10 ml iodized oil and gelfoam particles.
Embolization was performed again after 3 weeks and the
total number of the embolizations was two (Figure 4).
After completion of the second embolization, the
patient’s buttock pain improved significantly. Her gait
became normal. Radiography demonstrated many
iodized oil shadows in the osteolytic lesion involving
the sacrum and ilium (Figure 5). Then she underwentFigure 1 A 31-year-old woman presented with giant cell tumor involv
computerized tomography (CT) (b) shows an eccentric, geographic, destru
spine, with slight displacement of the pubic symphysis and left sacroiliac jotumor curettage and bone grafting with a combined
anterior-posterior approach under general anesthesia.
The first step was bilateral, internal, iliac artery ligation
through the anterior approach, and the tumor was removed
completely and bone grafting performed using the posterior
approach. The blood loss in the patient was 10 units
during the operation. At the final follow-up 9 years after
completion of the management, radiography showed
slight displacement of the pubic symphysis and sacroiliac
joint, and good bone healing with no local recurrence
(Figure 6). The patient returned to normal daily life activity.ing left sacroiliac joint. Preoperative radiography (a) and
ctive, osteolytic lesion involving the sacrum and posterior superior iliac
int (c).
Figure 3 Arteriogram at the time of presentation shows markedly
increased vascularity and uptake of contrast in the tumor.
Figure 5 Radiography following the second embolization
shows many iodized oil shadows in the osteolytic lesion.
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GCT involving the sacrum and ilium presents a significant
challenge and treatment methods, including surgical
resection and radiation, and is associated with morbid
complications and high recurrence rates [5,6]. Partial
and/or total resection of the tumor, including the
sacroiliac joint, can be an ideal therapeutic modality;
however, it can result in significant morbidity, including
neurological complication and infection, and mortality [7].
Intralesional curettage is the most common therapeutic
option for GCT of the bone, especially for lesions of theFigure 4 Arteriogram following the second embolization
demonstrating the vascularity pattern of successful embolization.extremities. However, the local recurrence rate after
intralesional curettage is relatively high, and excessive
intraoperative blood loss is often fatal [8]. More conserva-
tive surgical treatment has a high risk of local recurrence,
from that of 23% to 33%, and even 100%, after curettage
and cryotherapy [1].
Postoperative adjuvant therapy has a limited place in the
treatment of GCT. Radiotherapy has been abandoned,
since limited therapeutic benefit is combined with a risk
of malignant change [1]. Embolization was initially used
for inoperative primary or secondary bone tumors after
failure of other forms of treatment [9]. Interest in arterial
embolization of pelvic tumors followed its success as a
palliative measure, particularly after resolution of pain and
tumor shrinkage. As an alternative, minimally invasive
and effective conservative treatment for GCT of theFigure 6 At the postoperative 9-year follow-up radiography
shows slight displacement of the pubic symphysis and sacroiliac
joint and good bone healing with no tumor recurrence.
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and good long-term clinical results were demonstrated
[4,7,8,10]. Hosalkar et al. [3] reported that seven of their
nine cases had no disease progression at an average of 8.9
years of follow-up. Lin et al. [4] reported the clinical
results for more than 10 years of follow-up of 18 patients
treated with selective intra-arterial embolization. They
demonstrated that the risks of local recurrence were 31%
at 10 years, and 43% at 15 and 20 years, and concluded
that the response after embolization was durable in about
half of the patients. This technique has been shown to
devascularize tumors, reduce their size, cause calcification
of their margins and alleviate pain.
Previous reports demonstrated that a large population of
patients responded favorably to intra-arterial embolization,
with improvement in pain [1,3,4]. Rapid pain relief is one of
the greatest advantages of intra-arterial embolization
for GCT of the sacrum. With the treatment experi-
ence of five patients to examine the efficacy of serial
arterial embolization, Lackman et al. [1] concluded that
embolization was the primary therapy after histological
confirmation of the diagnosis, which therefore obviated
any exposure to chemotherapy or radiation. Our patient
could not walk because of severe buttock pain at first
presentation. This severe pain was probably due to de-
struction of the weight-bearing portion of the sacrum and
ilium. After completion of the second embolization, her
buttock pain improved significantly and her gait became
normal. These rapid responses to the embolization led to
the rapid pain relief in our patient.
These results prompted us to employ this therapeutic
modality for our patient to decrease bleeding during the op-
eration. After completion of preoperative selective arterial
embolization (SAE), she underwent tumor curettage and
bone grafting with a combined anterior-posterior approach.
We had enough time to completely remove the tumor
tissue and manage the tumor cavity to minimize blood loss.
At the final 9-year postoperative follow-up, there was no
local recurrence or metastasis, and the patient has returned
to normal life. The good long-term outcome suggests that
for this challenging disease, repeated preoperative SAE, cur-
ettage and bone grafting could be an effective and relatively
less complicated technique, resulting in less blood loss.Conclusion
We think it is an optimal treatment for giant cell tumor
involving the sacroiliac joint, with repeated selective arterial
embolization and curettage, which has the advantage of less
injury, less blood loss and fewer complications.Consent
Written informed consent was obtained from the patient
for publication of this Case report and any accompanyingimages. A copy of the written consent is available for
review by the Editor of this journal.
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